US Justice Department warns medtech industry of global bribery crackdown
This article was originally published in SRA
Executive Summary
The US Department of Justice is carrying out a formal investigation into the entire medical technology industry to “root out” behaviour that results in violations of the Foreign Corrupt Practices Act. The department’s foreign counterparts are also stepping up their anti-bribery enforcement efforts and so companies need to increase their focus on foreign bribery compliance, says Kathleen Hamann, a trial attorney in the fraud section of the DoJ’s Criminal Division. Karen Finn reports from the 2010 International Medical Device Industry Compliance Conference taking place this week in Berlin, Germany.
You may also be interested in...
Global medtech alliance approves six new member associations
An emerging alliance of medical technology industry associations representing innovative companies that currently develop and manufacture 85% of the world's medical devices, diagnostics and equipment has approved the membership applications of six more associations, bringing the total number of members to 19.
Global medtech alliance approves six new member associations
An emerging alliance of medical technology industry associations representing innovative companies that currently develop and manufacture 85% of the world's medical devices, diagnostics and equipment has approved the membership applications of six more associations, bringing the total number of members to 19.
US FDA scrutiny of DTC genetic tests continues
The US FDA's devices unit has written to three genetic testing companies warning them that they may be marketing their products and services without clearance by the agency.